DE69309454D1 - Pyridincarboximidamide und deren anwendung - Google Patents

Pyridincarboximidamide und deren anwendung

Info

Publication number
DE69309454D1
DE69309454D1 DE69309454T DE69309454T DE69309454D1 DE 69309454 D1 DE69309454 D1 DE 69309454D1 DE 69309454 T DE69309454 T DE 69309454T DE 69309454 T DE69309454 T DE 69309454T DE 69309454 D1 DE69309454 D1 DE 69309454D1
Authority
DE
Germany
Prior art keywords
carboximidamides
pyridine
effect
bisalkylsulfonylamino
nitroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69309454T
Other languages
English (en)
Other versions
DE69309454T2 (de
Inventor
Hideki Okawara
Tatsuo Nakajima
Nobuyuki Ogawa
Tomoko Kashiwabara
Soichiro Kaneta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Application granted granted Critical
Publication of DE69309454D1 publication Critical patent/DE69309454D1/de
Publication of DE69309454T2 publication Critical patent/DE69309454T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69309454T 1992-01-28 1993-01-28 Pyridincarboximidamide und deren anwendung Expired - Fee Related DE69309454T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1334292 1992-01-28
JP6622192 1992-03-24
JP32576092 1992-12-04
PCT/JP1993/000103 WO1993015057A1 (en) 1992-01-28 1993-01-28 Pyridinecarboximidamide compound and use thereof

Publications (2)

Publication Number Publication Date
DE69309454D1 true DE69309454D1 (de) 1997-05-07
DE69309454T2 DE69309454T2 (de) 1997-08-14

Family

ID=27280214

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69309454T Expired - Fee Related DE69309454T2 (de) 1992-01-28 1993-01-28 Pyridincarboximidamide und deren anwendung

Country Status (18)

Country Link
US (1) US5508293A (de)
EP (1) EP0634400B1 (de)
JP (1) JP2648395B2 (de)
KR (1) KR100249755B1 (de)
CN (1) CN1043760C (de)
AT (1) ATE151073T1 (de)
AU (1) AU674839B2 (de)
CA (1) CA2129013C (de)
DE (1) DE69309454T2 (de)
DK (1) DK0634400T3 (de)
ES (1) ES2100522T3 (de)
FI (1) FI105399B (de)
HK (1) HK1000094A1 (de)
HU (1) HU218487B (de)
MX (1) MX9300433A (de)
NO (1) NO302070B1 (de)
TW (1) TW232009B (de)
WO (1) WO1993015057A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
AU6016496A (en) * 1995-06-14 1997-01-15 Sankyo Company Limited Antianginal drug comprising nitroxy derivative as active ingredient
WO1998035673A1 (fr) * 1997-02-14 1998-08-20 Kirin Beer Kabushiki Kaisha Medicaments utilises dans la decongestion du flux sanguin peripherique
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
JP2003321329A (ja) * 2002-04-25 2003-11-11 Kirin Brewery Co Ltd 育毛剤
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
AU2004220548A1 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
TW200908984A (en) 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
EP3088390A1 (de) 2015-04-30 2016-11-02 Bayer CropScience AG Katalytische hydrierung von substituierten cyanopyridinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95244C (fi) * 1988-12-27 1996-01-10 Kirin Brewery Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja
JPH0662567B2 (ja) * 1988-12-27 1994-08-17 麒麟麦酒株式会社 ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
JP2846070B2 (ja) * 1989-11-29 1999-01-13 麒麟麦酒株式会社 カルボキシイミダミド誘導体

Also Published As

Publication number Publication date
CA2129013C (en) 2001-08-14
CN1043760C (zh) 1999-06-23
DK0634400T3 (da) 1997-04-28
EP0634400A1 (de) 1995-01-18
FI943508A (fi) 1994-09-22
ES2100522T3 (es) 1997-06-16
DE69309454T2 (de) 1997-08-14
US5508293A (en) 1996-04-16
HUT70506A (en) 1995-10-30
ATE151073T1 (de) 1997-04-15
NO302070B1 (no) 1998-01-19
AU3367793A (en) 1993-09-01
HU9402218D0 (en) 1994-09-28
CN1077949A (zh) 1993-11-03
TW232009B (de) 1994-10-11
HU218487B (hu) 2000-09-28
HK1000094A1 (en) 1997-11-21
NO942740D0 (no) 1994-07-22
KR100249755B1 (ko) 2000-04-01
NO942740L (no) 1994-09-27
JP2648395B2 (ja) 1997-08-27
WO1993015057A1 (en) 1993-08-05
MX9300433A (es) 1994-07-29
KR950700255A (ko) 1995-01-16
FI943508A0 (fi) 1994-07-26
FI105399B (fi) 2000-08-15
CA2129013A1 (en) 1993-07-29
EP0634400A4 (de) 1995-06-14
EP0634400B1 (de) 1997-04-02
AU674839B2 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
DE69309454D1 (de) Pyridincarboximidamide und deren anwendung
IL148516A (en) Retroviral protease inhibiting compound
AU537414B2 (en) Pyroglutamic acid derivatives
ATE240734T1 (de) Zubereitung von xanthinderivaten als feste dispersion
EP0906907A4 (de)
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
TW223637B (de)
DK0676399T3 (da) Methotrexaderivater
AU740079C (en) Antirheumatic agents
KR960702307A (ko) 항불안약 (anxiolytic agent)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee